Muscarinic type-1 receptors contribute to I in human atrial cardiomyocytes and are upregulated in patients with chronic atrial fibrillation.

Jordi Heijman, Dorit Kirchner, Franziska Kunze, Eva Maria Chrétien, Martina B Michel-Reher, Niels Voigt, Michael Knaut, Martin C Michel, Ursula Ravens, Dobromir Dobrev

Journal: International journal of cardiology 2018;255():61-68

PMID: 29290419

Abstract

BACKGROUND

Basal and acetylcholine-gated inward-rectifier K-currents (I and I, respectively) are altered in atrial fibrillation (AF). G-protein-coupled muscarinic (M) receptors type-2 are considered the predominant receptors activating I. Although a role for G-coupled non-M-receptor subtypes has been suggested, the precise regulation of I by multiple M-receptor subtypes in the human atrium is unknown. Here, we investigated M-receptor-mediated I regulation and its remodeling in chronic AF (cAF).

METHODS AND RESULTS

M-receptor mRNA and protein abundance were increased in atrial cardiomyocyte fractions and atrial homogenates from cAF patients, whereas M-receptor levels were unchanged. The regulation of I by M-receptors was investigated in right-atrial cardiomyocytes using two applications of the M-receptor agonist carbachol (CCh, 2μM), with pharmacological interventions during the second application. CCh application produced a rapid current increase (Peak-I), which declined to a quasi-steady-state level (Qss-I). In sinus rhythm (Ctl) the selective M-receptor antagonists pirenzepine (10nM) and muscarinic toxin-7 (MT-7, 10nM) significantly inhibited CCh-activated Peak-I, whereas in cAF they significantly reduced both Peak- and Qss-I, with no effects on basal inward-rectifier currents in either group. Conversely, the selective M-receptor agonist McN-A-343 (100μM) induced a current similar to the CCh-activated current in Ctl atrial cardiomyocytes pretreated with pertussis toxin to inhibit M-receptor-mediated G-protein signaling, which was abolished by MT-7. Computational modeling indicated that M- and M-receptors redundantly activate I to abbreviate APD, albeit with predominant effects of M-receptors.

CONCLUSION

Our data suggest that G-coupled M-receptors also regulate human atrial I and that their relative contribution to I activation is increased in cAF patients. We provide novel insights about the role of non-M-receptors in human atrial cardiomyocytes, which may have important implications for understanding AF pathophysiology.

Copyright © 2017 Elsevier B.V. All rights reserved.

Address: Institute of Pharmacology, West German Heart and Vascular Center, Faculty of Medicine, University Duisburg-Essen, Essen, Germany; Department of Cardiology, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.; Department of Pharmacology and Toxicology, Carl Gustav Carus Medical Faculty, Dresden University of Technology, Dresden, Germany.; Department of Pharmacology, Johannes Gutenberg University, Mainz, Germany.; Institute of Pharmacology, West German Heart and Vascular Center, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.; Heart Surgery, Heart Center Dresden, Carl Gustav Carus Medical Faculty, Dresden University of Technology, Dresden, Germany.; Department of Pharmacology and Toxicology, Carl Gustav Carus Medical Faculty, Dresden University of Technology, Dresden, Germany; Institute of Experimental Cardiovascular Medicine, University Heart Center Freiburg-Bad Krozingen, Freiburg, Germany.; Institute of Pharmacology, West German Heart and Vascular Center, Faculty of Medicine, University Duisburg-Essen, Essen, Germany; Department of Pharmacology and Toxicology, Carl Gustav Carus Medical Faculty, Dresden University of Technology, Dresden, Germany. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.